<strong>Chest</strong> & <strong>Heart</strong> Journal Vol. <strong>35</strong>, <strong>No</strong>.-2, July <strong>2011</strong>pelvic infections 8,9,10 <strong>and</strong> occurs in 10% cases <strong>of</strong>pulmonary TB 8,10 . <strong>The</strong> first reported case <strong>of</strong>gynaecological TB was described by Morgagni in1744 11 .<strong>The</strong> prevalence <strong>of</strong> female GTB is largelyunderestimated as the disease <strong>of</strong>ten remains silentor may present with non-specificsymptomatology 3 . However a rising incidence,partly as a result <strong>of</strong> HIV p<strong>and</strong>emic 10,12,13 <strong>and</strong>emergence <strong>of</strong> resistant strains has beenreported 8,13 . Majority <strong>of</strong> patients are in thereproductive age group 5,8,9,14, but older womenare also known to harbour it 15 .This silent invader <strong>of</strong> genital tract tends to creatediagnostic dilemmas 7,13 & remains a challenge forthe clinicians. As there is no gold st<strong>and</strong>ard test 7 , ahigh index <strong>of</strong> clinical suspicion aided by a number<strong>of</strong> investigations may help to reach to a definitediagnosis. A combined approach involving arespiratory physician <strong>and</strong> gynaecologist may helpto achieve the optimum goal in diagnosis,treatment <strong>and</strong> follow-up particularly in dealing withthe multi-drug resistant TB (MDR-TB) cases. Anearly diagnosis is important otherwise many womenin their sexual prime are rendered infertile due toGTB 9 . <strong>The</strong> chances <strong>of</strong> pregnancy have so far beenpoor (5%) even after the completion <strong>of</strong> treatment 8 .Incidence :<strong>The</strong> exact incidence <strong>of</strong> female GTB is not knownpartly because more <strong>of</strong>ten the disease remainssilent <strong>and</strong> in addition there are lack <strong>of</strong> reliableconfirmatory investigations 10 . In developedcountries, such as USA, Australia <strong>and</strong> WesternEuropean countries, the incidence is les than 1percent 16,17 but the incidence in some Africancountries is as high as 15-19 percent 18,19 . <strong>The</strong>global prevalence <strong>of</strong> genital tuberculosis isestimated to be 8-10 million cases 20 with a risingtrend in some developing countries 12 . Increase inthe trend <strong>of</strong> this disease may be partly due to anoverall rise in tuberculosis cases 8,10 . <strong>The</strong> othercontributory factors may be HIV infection <strong>and</strong>emergence <strong>of</strong> drug resistant forms 8,13 . It isimportant to mention that, the incidence <strong>of</strong> TBhas decreased significantly worldwide during thelast 30 years 22 . However, the p<strong>and</strong>emic <strong>of</strong> HIVhas altered its incidence, morbidity <strong>and</strong> mortalityin less developed countries 12 .Situation in Bangladesh (BD) :According to WHO, Bangladesh ranks sixth amongcountries with high TB burden 23,24 . <strong>The</strong> estimatedprevalence <strong>and</strong> incidence rates <strong>of</strong> all forms <strong>of</strong> TBincluding HIV were respectively 411 <strong>and</strong> 225 per100,000 population <strong>and</strong> mortality rate excludingHIV was 43 per 100,000 in 2010 2 . But according toa nationwide Tuberculosis Disease – cum –Infection Prevalence Survey 2007-09 – a steepdecline in the number <strong>of</strong> TB cases among urbanpopulation has been registered 24 . <strong>The</strong> prevalence<strong>of</strong> female GTB is not known but there is a risk <strong>of</strong>resurgence <strong>of</strong> TB as the HIV burden has movedfrom low prevalence to ‘concentrated epidemic’following the publication <strong>of</strong> the HIV sero surveyresults <strong>of</strong> more than 5 percent among injectingdrug users 25 . Data from national drug resistancesurveys indicate low levels <strong>of</strong> MDR-TB. Isolatedsurvey have indicated that MDR-TB rates amongnewly diagnosed cases between 3% <strong>and</strong> 15.4% 23 .<strong>The</strong> proportion <strong>of</strong> HIV positive individuals amongTB cases has been estimated to be 0.1% <strong>and</strong> HIVprevalence is 7% among injecting drug users 23 .Impact <strong>of</strong> female GTB on reproductive health :Female GTB is one <strong>of</strong> the major causes for severetubal disease leading to infertility 3 . <strong>The</strong>re is awealth <strong>of</strong> literature on GTB <strong>and</strong> infertility 7 , beingfirst shown by Malkani et al. 26 . When TB affectsgenital organs <strong>of</strong> young females, it producesdevastating effects by causing irreversible damageto the fallopian tube resulting in infertility whichis difficult to cure both by medical <strong>and</strong> surgicalmethods 27,28 . Minimal damage may lead to ectopicpregnancy <strong>and</strong> extensive damage may lead tocomplete tubal occlusion 15 . Peritubal adhesions<strong>and</strong> tubo-ovarian mass have been found in 47.2%<strong>of</strong> cases 29 , Various grades <strong>of</strong> intra-uterine adhesion(Asherman’s syndrome) or nonreceptiveednometrium have been reported in associationwith GTB 30 .However, the average worldwide incidence <strong>of</strong>female genital TB in infertile population has beenreported as 5-10% 31,32 . Despite the advances inchemotherapy, with the WHO’s recommendedDOTS strategy 33 , pregnancy <strong>and</strong> live birth afterdiagnosis <strong>of</strong> GTB has been reported to be low <strong>and</strong>when it did occur was more likely to be an ectopicpregnancy or resulted in a spontaneous abortion34,<strong>35</strong> . Overall, the conception rate among women114
Female Genital Tuberculosis: An Evaluation <strong>and</strong> Diagnostic DilemmasMd. Khairul Hassan Jessy et al.with GTB varies from 10% to 20% throughout theworld 7 . Frydman et al suggest that IVF is the onlyeffective treatment for tuberculous infertiltiy 36 .Pathogenesis :GTB is almost always secondary to a TB elsewherein the body most commonly from lungs 8,9,37,38,39 .<strong>and</strong> sometimes from kidneys, gastrointestinal tract,bones <strong>and</strong> joints. <strong>The</strong> mode <strong>of</strong> spread is usuallyhaematogenous or lymphatic <strong>and</strong> occasionally viadirect contiguity with an intra-abdominal orperitoneal focus 37 . Primary TB infection <strong>of</strong> thefemale genital tract is extremely rare but it mayoccur when the male partner has activegenitourinary TB, during orogenital sex or directinoculation at sexual intercourse <strong>and</strong> ascendingspread from the vagina, cervix <strong>and</strong> thevulva 22 .Following secondary or primary infection,the fallopian tubes are believed to be the initial<strong>and</strong> most frequently affected genital organ followedby endometrium 8,9,17,40,41 . Frequency <strong>of</strong>involvement include fallopian tubes (90-100%),endometrium (50-60%), ovaries (20-30%), cervix (5-15%) <strong>and</strong> vulva & vagina – 1%. <strong>The</strong> infective agentis Mycobacterium tuberculosis, occasionally M.bovis may cause human disease 9 .<strong>The</strong> primary focus is <strong>of</strong>ten quiescent or healed bythe time the genital lesion becomes active <strong>and</strong> thata long latent period <strong>of</strong> may years may intervenebetween the primary affliction <strong>and</strong> the appearance<strong>of</strong> GTB 9,43,44 . <strong>The</strong> incidence <strong>of</strong> active TB in infectedindividuals in only 10% 45,46 . Depending on thevirulence <strong>of</strong> the organism <strong>and</strong> immune responsegenerated by the host, the disease remains eitheractive or becomes asymptomatic with latentinfection persisting for many years 47 . Latentinfected individuals contain dormant yet viablebacilli which may reactivate when the hostresponse becomes low. During reactivation, thebacilli induce immune modulation <strong>and</strong> there isrelease <strong>of</strong> harmful cytokines like IL2, TNF alpha<strong>and</strong> INFgamma 48 .Pathology :<strong>The</strong> essential pathology in TB is the production <strong>of</strong>a characteristic lesion, the tubercle. This is anavascular granuloma, composed <strong>of</strong> a central zonecontaining giant cells, with or without caseation<strong>and</strong> a peripheral zone <strong>of</strong> lymphocytes &fibroblasts 10 .Clinical pr<strong>of</strong>ile :Female GTB is a disease <strong>of</strong> varied symptomatology.<strong>The</strong> disease is <strong>of</strong>ten discovered incidentally inmany patients <strong>and</strong> remains undiscovered in a largenumber <strong>of</strong> symptom less patients <strong>35</strong> . About 10-11%<strong>of</strong> patients are asymptomatic. A history <strong>of</strong> poorgeneral health persisting over months or yearsassociated with weight loss, undue fatigue, lowgrade fever or vague abdominal discomfort is <strong>of</strong>tenelicited. In 30-50% <strong>of</strong> cases there is history <strong>of</strong>diagnosis/ treatment for extragenital TB 17,49 <strong>and</strong>in about 20% there is history <strong>of</strong> TB in immediatefamily 17 . <strong>The</strong> four major presenting complaintsare infertility, menstrual disturbances, pelvic pain<strong>and</strong> swelling 22 . Infertility is the most commonpresentation with an incidence ranging from 40-75% 6,34 . Menstrual disturbances may be in the form<strong>of</strong> amenorrhoea (usually secondary), menorrhagia,metrorrhagia, oligomenorrhoea, <strong>and</strong> v. rarelypostmenopausal bleeding 43,44 . In about 4%, it isthe cause <strong>of</strong> puberty menorrhagia 9 . <strong>The</strong>re may be<strong>of</strong>fensive discharge & post coital bleeding as ininvolvement <strong>of</strong> cervix 38 , <strong>and</strong> painful shallow ulcerin the vulva/vagina 9,50 . Physical examinationfindings may be normal in upto 50% <strong>of</strong> cases 28,41,49when abnormal findings are present, adnexal massor signs <strong>of</strong> ascities are common. Adnexal massvary in size <strong>and</strong> consistency <strong>and</strong> results fromconglomeration <strong>of</strong> pelvic organs matted togetherby adhesions 39 .Diagnostic Dilemmas in clinical evaluation :GTB can mimic ovarian cancer <strong>and</strong> diagnosis isonly made after laparotomy 39 ; Pelvic inflammatorydisease, <strong>of</strong>ten recurrent <strong>and</strong> failing to respond tost<strong>and</strong>ard treatment , is <strong>of</strong>ten due to GTB 9 ; If ayoung girl with puberty menorrhagia fails torespond to st<strong>and</strong>ard hormonal therapy, she shouldbe investigated for GTB 9 ; A pelvic inflammatorymass in a virgin girl, may be due to GTB 9 ; Patientswith post-menopausal bleeding should be screenedfor GTB after excluding mailgnancy 9 ; Cervical TBmay mimic cancer 9,38,51 . Patients with infertility<strong>and</strong> menstrual disturbance should raise thesuspicion <strong>of</strong> GTB 9 . Sometimes the patients maypresent with pyrexia <strong>of</strong> undetermined origin 52 .Investigations :Due to the asymptomatic nature / varied clinicalpresentation, clinical diagnosis <strong>of</strong> genital TB isdifficult 53,54 . Moreover, the criteria for a definitive115
- Page 3 and 4: THE CHEST & HEART ASSOCIATION OF BA
- Page 5 and 6: Chest & Heart JournalVol. 35, No. 2
- Page 7 and 8: Instruction to Authors About Unifor
- Page 9 and 10: Chest & Heart JournalVol. 35, No. 2
- Page 11 and 12: Assessment of Diagnostic Value of C
- Page 13 and 14: Assessment of Diagnostic Value of C
- Page 16 and 17: Chest & Heart Journal Vol. 35, No.-
- Page 18 and 19: Chest & Heart JournalVol. 35, No. 2
- Page 20 and 21: Chest & Heart Journal Vol. 35, No.-
- Page 22 and 23: Chest & Heart Journal Vol. 35, No.-
- Page 24 and 25: Chest & Heart Journal Vol. 35, No.-
- Page 26 and 27: Chest & Heart Journal Vol. 35, No.-
- Page 28 and 29: Chest & Heart Journal Vol. 35, No.-
- Page 30 and 31: Chest & Heart Journal Vol. 35, No.-
- Page 32 and 33: Chest & Heart Journal Vol. 35, No.-
- Page 34 and 35: Chest & Heart Journal Vol. 35, No.-
- Page 36 and 37: Chest & Heart Journal Vol. 35, No.-
- Page 38 and 39: Chest & Heart Journal Vol. 35, No.-
- Page 40 and 41: Chest & Heart Journal Vol. 35, No.-
- Page 42 and 43: Chest & Heart Journal Vol. 35, No.-
- Page 44 and 45: Chest & Heart Journal Vol. 35, No.-
- Page 48 and 49: Chest & Heart Journal Vol. 35, No.-
- Page 50 and 51: Chest & Heart Journal Vol. 35, No.-
- Page 52 and 53: Chest & Heart JournalVol. 35, No. 2
- Page 54 and 55: Chest & Heart Journal Vol. 35, No.-
- Page 56 and 57: Chest & Heart Journal Vol. 35, No.-
- Page 58 and 59: Chest & Heart Journal Vol. 35, No.-
- Page 60 and 61: Chest & Heart Journal Vol. 35, No.-
- Page 62 and 63: Chest & Heart Journal Vol. 35, No.-
- Page 64 and 65: Chest & Heart JournalVol. 35, No. 2
- Page 66 and 67: Chest & Heart Journal Vol. 35, No.-
- Page 68 and 69: Chest & Heart Journal Vol. 35, No.-
- Page 70 and 71: Chest & Heart Journal Vol. 35, No.-